<?xml version="1.0" encoding="UTF-8"?>
<fig id="molecules-23-02974-f003" orientation="portrait" position="float" class="fig">
 <label class="label">Figure 3</label>
 <caption class="caption">
  <p class="p">In vivo antitumor activity of the essential oil (EO) from the leaves of 
   <italic class="italic">Croton matourensis</italic> in C.B-17 severe combined 
   <italic class="italic"/>immunodeficient (SCID) mice with HepG2 cell xenografts. (
   <bold class="bold">A</bold>) Tumor weight (g) after treatment. (
   <bold class="bold">B</bold>) Tumor inhibition (%) after treatment. Beginning 1 day after tumor implantation, the animals were treated through the intraperitoneal route for 21 consecutive days. The negative control (CTL) was treated with the vehicle (5% DMSO) used for diluting the EO. 5-Fluorouracil (5-FU, 10 mg/kg/day) was used as the positive control. Data are presented as means ± SEM. of 10–20 animals. * 
   <italic class="italic">P</italic> &lt; 0.05 compared to the negative control by ANOVA followed by Bonferroni’s multiple comparison test.
  </p>
 </caption>
 <graphic xlink:href="molecules-23-02974-g003" class="graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
